Performance of Ambulatory Electrocardiographic Data for Prediction of Stroke and Heart Failure Events
- PMID: 39497946
- PMCID: PMC11533076
- DOI: 10.1016/j.jacadv.2024.101340
Performance of Ambulatory Electrocardiographic Data for Prediction of Stroke and Heart Failure Events
Abstract
Background: Despite clear associations between arrhythmia burden and cardiovascular risk, clinical risk scores that predict cardiovascular events do not incorporate individual-level arrhythmia characteristics from long-term continuous monitoring (LTCM).
Objectives: This study evaluated the performance of risk models that use data from LTCM and patient claims for prediction of heart failure (HF) and ischemic stroke.
Methods: We retrospectively analyzed features extracted from up to 14 days of LTCM electrocardiogram (ECG) data linked to patient-level claims data for 320,974 Medicare beneficiaries who underwent ZioXT ambulatory monitoring. We created predictive models for HF hospitalization, stroke hospitalization, and new-onset HF within 1 year using LASSO Cox regression for variable selection among ambulatory ECG variables and components of the CHA2DS2-VASc score.
Results: A model that included components of the CHA2DS2-VASc and all ambulatory ECG variables had greater discrimination for HF hospitalization (C-statistic 0.85, 95% CI: 0.84-0.86) than the CHA2DS2-VASc (C-statistic 0.73, 95% CI: 0.72-0.74), but performed similarly to the CHA2DS2-VASc for prediction of stroke hospitalization (C-statistic 0.75 [95% CI: 0.74-0.77] vs 0.71 [95% CI: 0.70-0.72], respectively). Atrial fibrillation was associated with greater risk in the most predictive models (HF hospitalization, HR: 1.53 [95% CI: 1.35-1.72]; stroke hospitalization, HR: 1.58 [95% CI: 1.30-1.93]), and premature ventricular couplets were associated with greater risk of HF hospitalization (HR: 1.54, 95% CI: 1.43-1.65).
Conclusions: The CHA2DS2-VASc performed modestly for prediction of stroke and HF events; predictive ability improved significantly with addition of LTCM ECG covariates. The presence of atrial fibrillation and ventricular ectopy on 14-day LTCM were strongly associated with HF events.
Keywords: CHA2DS2-VASc; ambulatory ECG monitoring; arrhythmia; hospitalization; risk prediction.
© 2024 Published by Elsevier on behalf of the American College of Cardiology Foundation.
Conflict of interest statement
This project was funded by a research grant from 10.13039/100006983iRhythm Technologies, Inc. Dr Piccini is supported by R01AG074185 from the National Institutes of Aging. He also receives grants for clinical research from Abbott, the American Heart Association, Bayer, Boston Scientific, iRhythm, and Philips; and serves as a consultant to Abbott, Abbvie, Bayer, Boston Scientific, Element Science, Medtronic, Milestone, ElectroPhysiology Frontiers, Medtronic, Sanofi, Pacira, Philips, and Up-to-Date. Dr Turakhia has received research grants from Bristol Myers Squibb, 10.13039/100000968American Heart Association, 10.13039/100004326Bayer, 10.13039/100005564Gilead Sciences, and the 10.13039/100000038Food and Drug Administration; equity from iRhythm, Connect America, Forward, Evidently, and PocketRN. Dr Hytopoulos, Dr Turakhia, and JC are employees of iRhythm Technologies Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures



Similar articles
-
CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.Cardiovasc Drugs Ther. 2020 Dec;34(6):763-772. doi: 10.1007/s10557-020-07011-y. Cardiovasc Drugs Ther. 2020. PMID: 32583288
-
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725. JAMA. 2015. PMID: 26318604
-
Stroke risk scores to predict hospitalization for acute decompensated heart failure in atrial fibrillation patients.Rom J Intern Med. 2021 Mar 5;59(1):73-82. doi: 10.2478/rjim-2020-0032. Print 2021 Mar 1. Rom J Intern Med. 2021. PMID: 33125341
-
Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis.Eur J Prev Cardiol. 2022 Mar 30;29(4):625-631. doi: 10.1093/eurjpc/zwab018. Eur J Prev Cardiol. 2022. PMID: 33693717
-
Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.Tex Heart Inst J. 2015 Feb 1;42(1):6-15. doi: 10.14503/THIJ-14-4353. eCollection 2015 Feb. Tex Heart Inst J. 2015. PMID: 25873792 Free PMC article. Review.
References
-
- Joglar J.A., Chung M.K., Armbruster A.L., et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2023;149(1):e1–e156. - PMC - PubMed
-
- Melgaard L., Gorst-Rasmussen A., Lane D.A., Rasmussen L.H., Larsen T.B., Lip G.Y.H. Assessment of the CHA 2 DS 2 -VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA. 2015;314:1030. - PubMed
-
- Paoletti Perini A., Bartolini S., Pieragnoli P., et al. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy. Europace. 2014;16:71–80. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous